For research use only. Not for therapeutic Use.
CD-1530 (Cat.No:I005904) is a retinoic acid receptor γ selective agonist. Inquire CD-1530 online by filling out the inquiry form, we will get back to you within 24 hours!
| Catalog Number | I005904 |
| CAS Number | 107430-66-0 |
| Synonyms | CD1530; CD 1530; CD-1530.;4-(7-((3r,5r,7r)-adamantan-1-yl)-6-hydroxynaphthalen-2-yl)benzoic acid |
| Molecular Formula | C27H26O3 |
| Purity | ≥95% |
| Target | Vitamin D Related/Nuclear Receptor |
| Solubility | Soluble in DMSO, not in water |
| Storage | Store at 4°C |
| IUPAC Name | 4-[7-(1-adamantyl)-6-hydroxynaphthalen-2-yl]benzoic acid |
| InChI | InChI=1S/C27H26O3/c28-25-12-22-6-5-21(19-1-3-20(4-2-19)26(29)30)10-23(22)11-24(25)27-13-16-7-17(14-27)9-18(8-16)15-27/h1-6,10-12,16-18,28H,7-9,13-15H2,(H,29,30) |
| InChIKey | VCQGNUWOMLYNNG-UHFFFAOYSA-N |
| SMILES | C1C2CC3CC1CC(C2)(C3)C4=C(C=C5C=CC(=CC5=C4)C6=CC=C(C=C6)C(=O)O)O |
| Reference | </br>1: Tang XH, Osei-Sarfo K, Urvalek AM, Zhang T, Scognamiglio T, Gudas LJ. Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide. Proc Natl Acad Sci U S A. 2014 Jun 17;111(24):8907-12. doi: 10.1073/pnas.1404828111. Epub 2014 Jun 3. PubMed PMID: 24927566; PubMed Central PMCID: PMC4066471. |
